Recursion Pharmaceuticals exceeded EPS expectations by 15.38%. The company reported a significant revenue shortfall, missing forecasts by 60.26%. Pre-market stock price fell 1.84% amid broader biotech ...

"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

In 2021, dermatologist David Ozog was on holiday with his family in the Bahamas, when his 18-year-old son had a massive stroke. The teenager was airlifted to Florida, and then to Chicago for surgery.

Osteoarthritis is a common degenerative joint disease that causes pain, stiffness and swelling, and reduces your range of motion. It often affects the knees, hips and hands, although it can also occur ...

PyPy, an alternative runtime for Python, uses a specially created JIT compiler to yield potentially massive speedups over CPython, the conventional Python runtime. But PyPy’s exemplary performance has ...

Paria Sanaty Zadeh is a licensed pharmacist and associate director of the practice and science programs with the American Pharmacists Association. It can take weeks for magnesium supplements to ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

No one wants to be that coworker. You know, the one everyone talks about after a work party. Work gatherings can be a great way to connect with your colleagues and celebrate your professional ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In the year-plus since ...